Articles

Cancer-associated Thrombosis at ASH 2019
News

Cancer-associated Thrombosis at ASH 2019

We are happy to announce that ASH will be sponsoring a Scientific Workshop on Cancer Associated Thrombosis.

Read More
Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy
Risk Factors

Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy

Approximately 4% of cancer patients have non-valvular atrial fibrillation (NVAF) and require anticoagulation for prophylaxis against embolic stroke.

Read More
Managing antiplatelet therapy in thrombocytopenic patients with hematological malignancy
Anticoagulation Drugs

Managing antiplatelet therapy in thrombocytopenic patients with hematological malignancy

The use of antiplatelet therapy, prescribed for acute and chronic ischemic arterial disease, is frequently encountered in cancer patients. A clinical vignette-based experiment was designed to mimic the clinical scenarios in which decision-making occurs.

Read More
Cancers as coagulant mosaics
Basic Mechanism

Cancers as coagulant mosaics

Cancers are potent inducers of abnormal blood clotting, which usually heralds a more aggressive course of the disease and poor prognosis...

Read More
Cancer associated thrombosis at ISTH: what not to miss
News

Cancer associated thrombosis at ISTH: what not to miss

What’s of interest for us cancer-associated thrombosis specialists?

Read More
ICTHIC at ISTH 2019 - come find us
News

ICTHIC at ISTH 2019 - come find us

This year ICTHIC Magazine is travelling all the way to Melbourne in order to attend the 26th ISTH.

Read More
Arterial Thromboembolism in Occult Cancer
Basic Mechanism

Arterial Thromboembolism in Occult Cancer

In 1865, Armand Trousseau famously described unexplained thrombotic events as a first manifestation of occult malignancy. His documented cases mainly concerned venous thromboembolic events such as migratory thrombophlebitis...

Read More
Contemporary breast cancer treatment-associated venous thromboembolism
Solid Tumors

Contemporary breast cancer treatment-associated venous thromboembolism

Breast cancer treatment, in particular surgery, chemotherapy and endocrine therapy, significantly escalates the risk of VTE further

Read More
The XXVII Congress of the International Society on Thrombosis and Haemostasis
News

The XXVII Congress of the International Society on Thrombosis and Haemostasis

Find us at booth #1113 in the exhibition area. We have some surprises for you in store.

Read More
Mouse models of cancer-associated thrombosis
Basic Mechanism

Mouse models of cancer-associated thrombosis

The incidence of VTE is varied with cancer type, suggesting that there may be cancer-type specific mechanisms. However, the underlying mechanisms have not been elucidated. Mouse models are used to investigate the mechanisms of cancer-associated thrombosis. Many different mouse models have been established that vary by mouse strains, cancer cells, tumor sites and thrombosis models.

Read More

Page 1 of 7